European Heart Journal-Quality of Care and Clinical Outcomes

Article	Citations
Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs	124
The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review	117
Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic	56
Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: results from the All Nippon AF In the Elderly (ANAFIE) Registry	54
European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary	50
Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews	36
Peak oxygen consumption achieved at the end of cardiac rehabilitation predicts long-term survival in patients with coronary heart disease	32
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis	27
A comparative analysis of premature heart disease- and cancer-related mortality in women in the USA, 1999–2018	27
Types of myocardial injury and mid-term outcomes in patients with COVID-19	27
Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines	27
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation	26
Improving dynamic stroke risk prediction in non-anticoagulated patients with and without atrial fibrillation: comparing common clinical risk scores and machine learning algorithms	26
The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry)	26
Refined staging classification of cardiac damage associated with aortic stenosis and outcomes after transcatheter aortic valve implantation	25
Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study	25
Management of aortic stenosis: a systematic review of clinical practice guidelines and recommendations	25
Representativeness in randomised clinical trials supporting acute coronary syndrome guidelines	24
Temporal trends of mortality in patients with infective endocarditis: a nationwide study	21
European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment	20
Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry	20
Ethnic disparities in care and outcomes of non-ST-segment elevation myocardial infarction: a nationwide cohort study	20
Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990–2019	19
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrilla	19
Development of an international standard set of clinical and patient-reported outcomes for children and adults with congenital heart disease: a report from the International Consortium for Health Outc	18

Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Progr	17
Predicting the EQ-5D utilities from the Kansas City Cardiomyopathy Questionnaire in patients with heart failure	17
Cost-effectiveness analysis of screening for first-degree relatives of patients with bicuspid aortic valve	17
Effect of coronary artery bypass grafting on quality of life: a meta-analysis of randomized trials	17
Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019	17
Gender differences in complications following catheter ablation of atrial fibrillation	16
Generalizability of randomized controlled trials in heart failure with reduced ejection fraction	16
Cardiac rehabilitation for patients with heart failure: association with readmission and mortality risk	16
Sex differences in mortality and 90-day readmission rates after transcatheter aortic valve replacement: a nationwide analysis from the USA	16
Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term exten	16
Ten-year trends in mortality and complications following catheter ablation of atrial fibrillation	16
Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Re	16
Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices)	15
Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study	15
Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries	14
Methodology for the development of international clinical data standards for common cardiovascular conditions: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)	14
High-statin adherence over 5 years of follow-up is associated with improved cardiovascular outcomes in patients with atherosclerotic cardiovascular disease: results from the IMPRES study	14
The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study	13
Patient-reported outcome measures in cardiovascular disease	13
Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials	13
Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapies	13
Global representation of heart failure clinical trial leaders, collaborators, and enrolled participants: a bibliometric review 2000–20	13
Has the first year of the COVID-19 pandemic reversed the trends in CV mortality between 1999 and 2019 in the United States?	12
Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk	12
Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry	12
Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis)	12
The PRECISE-DAPT score and 5-year outcomes after percutaneous coronary intervention: a large-scale, real-world study from China	11
Machine learning-based identification of risk-factor signatures for undiagnosed atrial fibrillation in primary prevention and post-stroke in clinical practice	11
Trends in treatment and outcomes of atrial fibrillation during 2007–17 in Finland	11
Alerting trends in epidemiology for calcific aortic valve disease, 1990–2019: An age–period–cohort analysis for the Global Burden of Disease Study 2019	11
Comparative efficacy and safety of different catheter ablation strategies for persistent atrial fibrillation: a network meta-analysis of randomized clinical trials	11
Transcatheter aortic valve replacement in mixed aortic valve disease: a systematic review and meta-analysis	11
EURObservational Research Programme: a bibliometric assessment of its scientific output	10
The association between cardiovascular disease admission rates and the coronavirus disease 2019 lockdown and reopening of a nation: a Danish nationwide cohort study	10
Targeted vs. full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom	10
Importance of diagnostic setting in determining mortality in patients with new-onset heart failure: temporal trends in Denmark from 1997 to 2017	10
Impact of cancer diagnosis on distribution and trends of cardiovascular hospitalizations in the USA between 2004 and 2017	10
Longitudinal management and outcomes of acute coronary syndrome in persons living with HIV infection	9
Cardiovascular disease burden due to productivity losses in European Society of Cardiology countries	9
Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019	9
Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040	8
Management of mitral stenosis: a systematic review of clinical practice guidelines and recommendations	8
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study	8
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry	8
Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study	8
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs. without left ventricular unloading by Impella: a systematic review and meta-analysis	8
Critical Care Cardiology Trials Network (CCCTN): a cohort profile	8
Potential for optimizing management of obesity in the secondary prevention of coronary heart disease	8
The influence of the 2020 COVID-19 pandemic on the implantation rates of cardiac implantable electronic devices in Germany: changes between 2020 Q1–Q3 and 2019 Q1–Q3	8
Estimating the cost-effectiveness of screening a general population for cardiovascular risk with high-sensitivity troponin-I	8

Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis	7
Atrial fibrillation and chronic obstructive pulmonary disease: diagnostic sequence and mortality risk	7
The impact of atrial fibrillation on prognosis in aortic stenosis	7
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study	7
Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost–effectiveness and cost–utility analyses	7
Adherence to risk-assessment protocols to guide computed tomography pulmonary angiography in patients with suspected pulmonary embolism	7
Cost-effectiveness ofCYP2C19-guided P2Y12 inhibitors in Veterans undergoing percutaneous coronary intervention for acute coronary syndromes	7
A hidden problem: peripheral artery disease in women	7
Impact of the admitting ward on care quality and outcomes in non-ST-segment elevation myocardial infarction: insights from a national registry	7
Concurrent use of P-glycoprotein or Cytochrome 3A4 drugs and non-vitamin K antagonist oral anticoagulants in non-valvular atrial fibrillation	7
Left atrial appendage occlusion in the UK: prospective registry and data linkage to Hospital Episode Statistics	7
Quality indicators in the management of elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF)	7
Case-ascertainment of acute myocardial infarction hospitalizations in cancer patients: a cohort study using English linked electronic health data	7
Tricuspid regurgitation management: a systematic review of clinical practice guidelines and recommendations	6
Causes, pattern, predictors, and prognostic implications of new hospitalizations after transcatheter aortic valve implantation: a long-term nationwide observational study	6
Diabetes mellitus and outcomes of lower extremity revascularization for peripheral artery disease	6
The utility of implantable loop recorders in patient management: an age- and indication-stratified study in the outpatient-implant era	6
Outcomes of ST elevation myocardial infarction in patients with cancer: a nationwide study	6
Tuning and external validation of an adult congenital heart disease risk prediction model	6
Implications of structural right ventricular involvement in patients with hypertrophic cardiomyopathy	6
Prognostic value of modified model for end-stage liver disease scores in patients with significant tricuspid regurgitation	6
The cost-effectiveness of one-time opportunistic screening for atrial fibrillation in different age cohorts of inhabitants in Denmark aged 65 years and above: a Markov modelled analysis	6
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus	6
Transradial versus transfemoral approach for percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a systematic review and meta-analy	6
Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction: novel insights from four national European continuous real-world registries	6
Sex disparity in secondary prevention pharmacotherapy and clinical outcomes following acute coronary syndrome	6
The association between urinary sodium concentration (UNa) and outcomes of acute heart failure: a systematic review and meta-analysis	6
Temporal trends in major cardiovascular events following first-time myocardial infarction in the reperfusion era – a Danish nationwide cohort study from 2000 to 2017	6
Aortic regurgitation management: a systematic review of clinical practice guidelines and recommendations	5
Freedom from atrial arrhythmia and other clinical outcomes at 5 years and beyond after catheter ablation of atrial fibrillation: a systematic review and meta-analysis	5
Targeted atrial fibrillation detection in COVID-19 vaccination clinics	5
β-blocker adherence among patients with congenital long QT syndrome: a nationwide study	5
Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence	5
Occlusion of the infarct-related coronary artery presenting as acute coronary syndrome with and without ST-elevation: impact of inflammation and outcomes in a real-world prospective cohort	5
Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre study	5
Safety and efficacy of direct oral anticoagulants in patients with anaemia and atrial fibrillation: an observational nationwide Danish cohort study	5
Left ventricular thrombus in ischaemic heart disease: diagnosis, treatment, and gaps of knowledge	5
Cost-effectiveness of bilateral vs. single internal thoracic artery grafts at 10 years	5
Health Outcomes Management Evaluation—A National Analysis of Dutch Heart Care	5
Long-term outcome of children with newly diagnosed pulmonary arterial hypertension: results from the global TOPP registry	5
Which risk score best predicts cardiovascular outcome in pregnant women with congenital heart disease?	5
Admission rates and care pathways in patients with atrial fibrillation during the COVID-19 pandemic—insights from the German-wide Helios hospital network	5
Association of admitting physician specialty and care quality and outcomes in non-ST-segment elevation myocardial infarction (NSTEMI): insights from a national registry	4
Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study	4
The cardiovascular disease burden attributable to low physical activity in the Western Pacific Region, 1990–2019: an age–period–cohort analysis of the Global Burden of Disease study	4
Myocardial injury: a future challenge for long-COVID-19 complications	4
The impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review	4
Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology	4
Machine-learning versus traditional approaches for atherosclerotic cardiovascular risk prognostication in primary prevention cohorts: a systematic review and meta-analysis	4
Real-world management and outcomes of 7 million patients with acute coronary syndrome according to clinical research trial enrolment status: a propensity matched analysis	4
Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis	4
Mitral regurgitation management: a systematic review of clinical practice guidelines and recommendations	4
De-frailing intervention for hospitalized cardiovascular patients in the TARGET-EFT randomized clinical trial	4
Comparative analysis of machine learning vs. traditional modeling approaches for predicting in-hospital mortality after cardiac surgery: temporal and spatial external validation based on a nationwide	4
Optimal Heart Team Protocol to Improve Revascularization Decisions in Patients with Complex Coronary Artery Disease: A Sequential Mixed Method Study	4
A systematic assessment of the characteristics of randomized controlled trials cited by acute coronary syndrome clinical practice guidelines	4
Machine learning for prediction of all-cause mortality after transcatheter aortic valve implantation	4
The cost implications of a polypill for primary prevention in the TIPS-3 trial	4
Patient-reported vs. physician-estimated symptoms before and after transcatheter aortic valve replacement	4
True-severe stenosis in paradoxical low-flow low-gradient aortic stenosis: outcomes after transcatheter aortic valve replacement	4
European Society of Cardiology quality indicators for the cardiovascular pre-operative assessment and management of patients considered for non-cardiac surgery. Developed in collaboration with the Eur	4
Incidence of myocardial infarction, heart failure, and cardiovascular mortality in patients with peripheral artery disease: trends between 1997 and 2016	4
Temporal trend analysis of rheumatic heart disease burden in high-income countries between 1990 and 2019	4
Sex differences in temporal trends in main and secondary pulmonary embolism diagnosis and case fatality rates: 2003–2019	4
Quality improvement initiative in paediatric echocardiography laboratory in a low- to middle-income country	4
Identification of recurrent atrial fibrillation using natural language processing applied to electronic health records	4
Data standards for atrial fibrillation/flutter and catheter ablation: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)	4
Behavioural digital biomarkers enable real-time monitoring of patient-reported outcomes: a substudy of the multicentre, prospective observational SafeHeart study	4
Association between cancer, CHA2DS2VASc risk, and in-hospital ischaemic stroke in patients hospitalized for atrial fibrillation	4
Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention	4
Predictors of cumulative cost for patients with severe aortic stenosis referred for surgical or transcatheter aortic valve replacement: a population-based study in Ontario, Canada	4
Association between multimodality measures of aortic stenosis severity and quality-of-life improvement outcomes after transcatheter aortic valve replacement	3
Atrial fibrillation type and long-term clinical outcomes in hospitalized patients with heart failure: insight from JROADHF	3
Impact of multisite artery disease on clinical outcomes after percutaneous coronary intervention: an analysis from the e-Ultimaster registry	3
Association between Early Oral β-Blocker Therapy and Risk for In-Hospital Major Bleeding after Percutaneous Coronary Intervention for Acute Coronary Syndrome: Findings from CCC-ACS Project	3
European Society of Cardiology quality indicators for the care and outcomes of adults undergoing transcatheter aortic valve implantation	3
Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI	3
Clinical risk prediction models for the prognosis and management of acute coronary syndromes	3
Health-related quality-of-life up to one year after myocardial infarction with non-obstructive coronary arteries	3
Sex differences in clinical profile, management, and outcomes of patients hospitalized for atrial fibrillation in the United States	3

Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure?	3
Global, regional, and national burden of atrial fibrillation/flutter related to metabolic risks over three decades: estimates from the global burden of disease study 2019	3
Social determinants of health and recurrence of atrial fibrillation after catheter ablation: a Danish nationwide cohort study	3
Prediction models as gatekeepers for diagnostic testing in angina patients with suspected chronic coronary syndrome	3
What is next for screening for undiagnosed atrial fibrillation? Artificial intelligence may hold the key	3
What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey II	3
Do we need to reconsider how we design and conduct randomized controlled trials?	3
Future burden of myocardial infarction in Australia: impact on health outcomes between 2019 and 2038	3
New York Heart Association class is strongly associated with mortality beyond heart failure in symptomatic women	3
Association of autoimmune diseases with cardiomyopathy: a nationwide follow-up study from Sweden	3
Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017–2019	3
Sex-based differences in risk factors for incident myocardial infarction and stroke in the UK Biobank	3
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus: Reply	3
Long-term survival after surgical treatment for post-infarction mechanical complications: results from the Caution study	3
The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial	3
Economic burden of patients living with heart disease in the last years of life in Australia: a retrospective analysis using linked data	3
Real world evidence: Perspectives from a European Society of Cardiology Cardiovascular Round Table with contribution from the European Medicines Agency	3
Outcomes after coronary artery bypass grafting and percutaneous coronary intervention in diabetic and non-diabetic patients	3
Impact of age on outcomes after transcatheter aortic valve implantation	3
Impact of treatment adherence on the effectiveness and safety of oral anticoagulants in patients with atrial fibrillation: a retrospective cohort study	2
Association of acute increases in serum creatinine with subsequent outcomes in patients with type 2 diabetes mellitus treated with sodium–glucose cotransporter 2 inhibitor or dipeptidyl peptidase-4 in	2
Early goal-directed management after out-of-hospital cardiac arrest: lessons from a certified cardiac arrest centre	2
High risk of rehospitalization within 1 year following a pulmonary embolism—insights from the Danish nationwide registries from 2000–2020	2
Worldwide impact of COVID-19 on hospital admissions for non-ST-elevation acute coronary syndromes (NSTACS): a systematic review with meta-analysis of 553 038 cases	2
Cardiac rehabilitation, physical activity, and the effectiveness of activity monitoring devices on cardiovascular patients: an umbrella review of systematic reviews	2
Estimated annual healthcare costs after acute pulmonary embolism: results from a prospective multicentre cohort study	2
Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)	2
Serial cardiopulmonary exercise testing in young patients after one-and-half ventricle repair and Fontan procedure: a comparative study	2
New European Union law on medical devices: will it truly protect patients from malfunctioning cardiac implantable electronic devices?	2
Thirteen-year trends in cardiovascular risk in men and women with chronic coronary syndrome	2
Social determinants of health and catheter ablation after an incident diagnosis of atrial fibrillation: a Danish nationwide cohort study	2
Longitudinal risk of death, hospitalizations for atrial fibrillation, and cardiovascular events following catheter ablation of atrial fibrillation: a cohort study	2
Predictive and prognostic value of different cardiac troponin assays: a nationwide register-based cohort study	2
Contemporary trends in incident ischaemic stroke, intracranial haemorrhage, and mortality in individuals with atrial fibrillation	2
Outcomes with intracoronary vs. intravenous epinephrine in cardiac arrest	2
Transition to adult care of young people with congenital heart disease: impact of a service on knowledge and self-care skills and correlates of a successful transition	2
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease	2
Health economic consequences of optimal vs. observed guideline adherence of coronary angiography in patients with suspected obstructive stable coronary artery in Germany: a microsimulation model	2
Waiting times of women vs. men undergoing transcatheter aortic valve implantation	2
Diagnostic accuracy, clinical characteristics, and prognostic differences of patients with acute myocarditis according to inclusion criteria	2
Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands	2
Diabetes mellitus and presentation, care and outcomes of patients with NSTEMI: the Association for Acute Cardiovascular Care-European Association of Percutaneous Cardiovascular Interventions EURObserv	2
Risk of incident cardiovascular disease among patients with gastrointestinal disorder: a prospective cohort study of 330 751 individuals	2
The burden of cardiovascular disease attributable to high body mass index—an observational study	2
Urinary sodium: worth its salt?	2
Association of atrial fibrillation with survival in patients with low-flow low-gradient aortic stenosis with preserved ejection fraction undergoing TAVI	2
Low molecular weight heparin is associated with better outcomes than unfractionated heparin for thromboprophylaxis in hospitalized COVID-19 patients: a meta-analysis	2